Fertility and Sterility
Volume 93, Issue 8 , Pages 2615-2620 , 15 May 2010

The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase

Received 8 May 2009 ,Revised 5 September 2009 ,Accepted 8 September 2009.

References 

  1. Rama S, Rao AJ. Regulation of growth and function of the human placenta. Mol Cell Biochem. 2003;253:263–268
  2. Red-Horse K, Zhou Y, Genbachev O, Prakobhol A, Foulk R, McMaster M, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest. 2004;114:744–754
  3. Huddleston H, Schust DJ. Immune interactions at the maternal–fetal interface: a focus on antigen presentation. Am J Reprod Immunol. 2004;51:283–289
  4. Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy—an inflammatory view. Trends Immunol. 2006;27:399–404
  5. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol. 2005;5:835–843
  6. Johansson S, Berg L, Hall H, Höglund P. NK cells: elusive players in autoimmunity. Trends Immunol. 2005;26:613–618
  7. Orange JS, Ballas ZK. Natural killer cells in human health and disease. Clin Immunol. 2006;118:1–10
  8. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225–274
  9. Braud VM, Allan DS, McMichael AJ. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol. 1999;11:100–108
  10. Masilamani M, Nguyen C, Kabat J, Borrego F, Coligan JE. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol. 2006;177:3590–3596
  11. Burgess SJ, Maasho K, Masilamani M, Narayanan S, Borrego F, Coligan JE. The NKG2D receptor: immunobiology and clinical implications. Immunol Res. 2008;40:18–34
  12. Gunturi A, Berg RE, Forman J. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res. 2004;30:29–34
  13. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA. 1999;96:5674–5679
  14. Ntrivalas EI, Bowser CR, Kwak-Kim J, Beaman KD, Gilman-Sachs A. Expression of killer immunoglobulin-like receptors on peripheral blood NK cell subsets of women with recurrent spontaneous abortions or implantation failures. Am J Reprod Immunol. 2005;53:215–221
  15. Narvekar N, Cameron S, Critchley HO, Lin S, Cheng L, Baird DT. Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor. J Clin Endocrinol Metab. 2004;89:2491–2497
  16. Ghosh D, Sengupta J. Target-oriented anti-implantation approaches for pregnancy interception: experiences in the rhesus monkey model. Contraception. 2005;71:294–301
  17. Spitz IM. Progesterone receptor antagonists. Curr Opin Invest Drugs. 2006;7:882–890
  18. Antonakis N, Georgoulias V, Margioris AN, Stournaras C, Gravanis A. In vitro differential effects of the antiglucocorticoid RU486 on the release of lymphokines from mitogen-activated normal human lymphocytes. J Steroid Biochem Mol Biol. 1994;51:67–72
  19. Lalitkumar PG, Lalitkumar S, Meng CX, Stavreus-Evers A, Hambiliki F, Bentin-Ley U, et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod. 2007;22:3031–3037
  20. Danielsson KG, Marions L, Bygdeman M. Effects of mifepristone on endometrial receptivity. Steroids. 2003;68:1069–1075
  21. Zhu HX, Zhang WW, Zhuang YL, Huang LL. Mifepristone as an anti-implantation contraceptive drug: roles in regulation of uterine natural killer cells during implantation phase. Am J Reprod Immunol. 2009;61:68–74
  22. Sarkar NN. The potential of mifepristone (RU486) as a female contraceptive drug. Int J Clin Pract. 2002;56:140–144
  23. Nagashima S, Mailliard R, Kashii Y, Reichert TE, Herberman RB, Robbins P, et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood. 1998;91:3850–3861
  24. Guan TJ, Qin FJ, Du JH, Geng L, Zhang YY, Li M. AICAR inhibits proliferation and induced S-phase arrest, and promotes apoptosis in CaSki cells. Acta Pharmacol Sin. 2007;28:1984–1990
  25. Niekamp SR, Sutherland MA, Dahl GE, Salak-johnson JL. Immune responses of piglets to weaning stress: impacts of photoperiod. J Anim Sci. 2007;85:93–100
  26. Zhong-min GU, Zhong-sen MA, Ji-hong AN, Bo LI. Determination of NK cytotoxicity by improved MTT assay. J Jilin Univ (Med Ed). 2003;29:119–120
  27. Von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bártfai G. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomized trial. Lancet. 2002;360:1803–1810
  28. Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C, et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol. 2008;180:5746–5753
  29. Souza SS, Castro FA, Mendonca HC, Palma PV, Morais FR, Ferriani RA, et al. Influence of menstrual cycle on NK activity. J Reprod Immunol. 2001;50:151–159
  30. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol. 2003;50:351–354
  31. Hadinedoushan H, Mirahmadian M, Aflatounian A. Increased natural killer cell cytotoxicity and IL-2 production in recurrent spontaneous abortion. Am J Reprod Immunol. 2007;58:409–414
  32. Perricone R, Di Muzio G, Perricone C, Giacomelli R, De Nardo D, Fontana L, et al. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins. Am J Reprod Immunol. 2006;55:232–239
  33. Matsubayashi H, Hosaka T, Sugiyama Y, Suzuki T, Arai T, Kondo A, et al. Increased natural killer-cell activity is associated with infertile women. Am J Reprod Immunol. 2001;46:318–322
  34. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell?. Nat Immunol. 2002;3:6–8
  35. Hersey P, Bolhuis R. “Nonspecific” MHC-unrestricted killer cells and their receptors. Immunol Today. 1987;8:233–239
  36. Mcmahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, et al. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8 (+) T cells. J Immunol. 2002;169:1444–1452
  37. Masilamani M, Narayanan S, Prieto M, Borrego F, Coligan JE. Uncommon endocytic and trafficking pathway of the natural killer cell CD94/NKG2A inhibitory receptor. Traffic. 2008;9:1019–1034
  38. McGrath E, Ryan EJ, Lynch L, Golden-Mason L, Mooney E, Eogan M, et al. Changes in endometrial natural killer cell expression of CD94, CD158a and CD158b are associated with infertility. Am J Reprod Immunol. 2009;61:265–276
  39. Zhang Y, Zhao A, Wang X, Shi G, Jin H, Lin Q. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Fertil Steril. 2008;90:1931–1937
  40. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197–223

 X.-Y.C. has nothing to disclose. Y.-L.Z. has nothing to disclose. L.L. has nothing to disclose. W.-W.Z. has nothing to disclose. L.-L.H. has nothing to disclose.

PII: S0015-0282(09)03694-2

doi: 10.1016/j.fertnstert.2009.09.015

Fertility and Sterility
Volume 93, Issue 8 , Pages 2615-2620 , 15 May 2010

Article Tools

* Image Usage & Resolution